From November 3, 2023 to December 31, 2023, the company has repurchased 450,000 shares, representing 0.42% for CNY 14.76 million. With this, the company has completed the repurchase of 450,000 shares, representing 0.42% for CNY 14.76 million under the buyback announced on November 6, 2023.
Hangzhou Biotest Biotech Co.,Ltd.
Equities
688767
CNE1000050H0
Medical Equipment, Supplies & Distribution
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
28.53 CNY | -1.52% | -0.94% | -5.75% |
1st Jan change | Capi. | |
---|---|---|
-5.75% | 418M | |
-4.92% | 12.11B | |
-5.82% | 8.07B | |
+5.43% | 5.67B | |
+27.27% | 5.48B | |
-9.58% | 4.12B | |
-59.54% | 2.75B | |
+8.44% | 2.62B | |
-3.70% | 2.33B | |
+20.43% | 2.11B |
- Stock Market
- Equities
- 688767 Stock
- News Hangzhou Biotest Biotech Co.,Ltd.
- Tranche Update on Hangzhou Biotest Biotech Co.,Ltd.'s Equity Buyback Plan announced on November 6, 2023.